UMediC Group Berhad (KLSE:0256) — Stock Price
UMediC Group Berhad (KLSE:0256) is currently trading at RM0.31 MYR, up 0.00% today. Over the past 52 weeks, shares have ranged between RM0.28 and RM0.47. This page tracks UMediC Group Berhad's live share price on the KLSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see UMediC Group Berhad (0256) total market value.
UMediC Group Berhad (0256) Stock Price Chart — Daily History & Trading Volume
The chart below tracks UMediC Group Berhad's daily closing share price and trading volume on the KLSE exchange over the past year, giving a clear view of recent price momentum and liquidity.
UMediC Group Berhad Income Statement — Revenue, Profit & Earnings by Year
UMediC Group Berhad's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | RM48.56 Million | RM54.57 Million | RM45.43 Million | RM50.74 Million | RM34.12 Million |
| Cost of Revenue | RM26.20 Million | RM31.90 Million | RM26.50 Million | RM32.08 Million | RM21.55 Million |
| Gross Profit | RM22.36 Million | RM22.67 Million | RM18.93 Million | RM18.66 Million | RM12.56 Million |
| Research & Development | — | — | — | — | — |
| SG&A | RM12.69 Million | RM11.43 Million | RM7.64 Million | RM10.03 Million | RM5.88 Million |
| Total Operating Expenses | RM38.90 Million | RM43.33 Million | RM34.14 Million | RM42.11 Million | RM27.44 Million |
| Operating Income | RM9.67 Million | RM11.24 Million | RM11.29 Million | RM8.63 Million | RM6.68 Million |
| EBITDA | — | — | — | — | — |
| EBIT | — | — | — | — | — |
| Interest Expense | RM27.12K | RM99.08K | RM230.22K | RM798.33K | RM727.46K |
| Income Before Tax | RM10.85 Million | RM12.64 Million | RM12.93 Million | RM8.48 Million | RM6.55 Million |
| Income Tax Expense | — | — | — | — | — |
| Net Income | RM8.13 Million | RM8.99 Million | RM10.32 Million | RM6.43 Million | RM5.09 Million |
UMediC Group Berhad Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes UMediC Group Berhad's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | RM91.22 Million | RM82.71 Million | RM73.29 Million | RM68.89 Million | RM49.93 Million |
| Total Current Assets | RM52.79 Million | RM49.43 Million | RM43.82 Million | RM42.55 Million | RM23.32 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | RM4.95 Million | RM9.28 Million | RM11.87 Million | RM21.01 Million | — |
| Net Receivables | RM11.18 Million | RM17.42 Million | RM11.95 Million | RM6.18 Million | RM9.52 Million |
| Inventory | RM18.95 Million | RM14.57 Million | RM12.51 Million | RM9.46 Million | RM10.12 Million |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | RM287.00K | RM287.24K | RM287.24K | RM0.00 | — |
| Total Liabilities | RM9.87 Million | RM9.93 Million | RM9.82 Million | RM16.21 Million | RM34.19 Million |
| Total Current Liabilities | RM5.74 Million | RM6.02 Million | RM3.75 Million | RM7.37 Million | RM18.94 Million |
| Long-term Debt | RM0.00 | RM256.22K | RM2.88 Million | RM5.58 Million | RM14.16 Million |
| Net Debt | — | — | — | RM3.84 Million | RM22.43 Million |
| Total Stockholder Equity | RM80.12 Million | RM71.98 Million | RM62.99 Million | RM52.68 Million | RM15.74 Million |
| Retained Earnings | RM42.62 Million | RM34.49 Million | RM25.50 Million | RM15.18 Million | RM8.83 Million |
UMediC Group Berhad Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how UMediC Group Berhad generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | RM11.18 Million | RM4.32 Million | RM1.80 Million | RM8.48 Million | RM3.65 Million |
| Capital Expenditures | RM8.04 Million | RM6.31 Million | RM5.31 Million | RM1.01 Million | RM9.35 Million |
| Free Cash Flow | RM3.14 Million | RM-1.98 Million | RM-3.51 Million | RM7.47 Million | RM-5.70 Million |
| Investing Cash Flow | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | RM2.97 Million | RM2.50 Million | RM2.19 Million | RM1.75 Million | RM848.10K |
| Change in Cash | RM7.36 Million | RM-1.92 Million | RM2.07 Million | RM1.41 Million | RM-744.87K |
UMediC Group Berhad Earnings History — EPS Actual vs. Analyst Estimates
Track UMediC Group Berhad's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Dec 08, 2025 | 0.00 | — | — |
| Sep 11, 2025 | 0.01 | — | — |
| Jun 05, 2025 | 0.01 | — | — |
| Mar 11, 2025 | 0.01 | — | — |
| Dec 04, 2024 | 0.00 | — | — |
| Sep 04, 2024 | 0.01 | — | — |
| Jun 10, 2024 | 0.00 | — | — |
| Mar 11, 2024 | 0.01 | — | — |